Found 5 results
↓ CSVName | Type of Offering | Accepted Date |
---|---|---|
Nacuity Pharmaceuticals, Inc.
See All Filings
|
D | 2016-12-08 17:15:38 |
Amount To Be Raised
$2,500,000
Associated Brokers / Dealers
N/A
CIK Number
0001690279
Filed Document
0001250853-16-000186
Exclusions or Exemptions
506b
Accepted Date
2016-12-08 17:15:38
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
TEXAS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Nacuity Pharmaceuticals, Inc.
See All Filings
|
D | 2017-06-27 15:04:43 |
Amount To Be Raised
$10,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001690279
Filed Document
0001250853-17-000059
Exclusions or Exemptions
506b
Accepted Date
2017-06-27 15:04:43
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
TEXAS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Nacuity Pharmaceuticals, Inc.
See All Filings
|
D/A | 2017-07-20 16:17:38 |
Amount To Be Raised
$10,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001690279
Filed Document
0001250853-17-000065
Exclusions or Exemptions
506b
Accepted Date
2017-07-20 16:17:38
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
TEXAS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Nacuity Pharmaceuticals, Inc.
See All Filings
|
D/A | 2022-01-03 16:28:34 |
Amount To Be Raised
$17,400,000
Associated Brokers / Dealers
N/A
CIK Number
0001690279
Filed Document
0001690279-22-000001
Exclusions or Exemptions
506b
Accepted Date
2022-01-03 16:28:34
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
TEXAS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Nacuity Pharmaceuticals, Inc.
See All Filings
|
D | 2021-03-30 13:33:03 |
Amount To Be Raised
$11,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001690279
Filed Document
0001690279-21-000003
Exclusions or Exemptions
506b
Accepted Date
2021-03-30 13:33:03
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
TEXAS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|